Detection of Circulating Tumor DNA Using a Tissue-Free Epigenomic Assay is a Highly Prognostic Biomarker in Early-Stage Triple-Negative Breast Cancer.
Clinical cancer research an official journal of the American Association for Cancer Research（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined